Adult height after growth hormone (GH) treatment for GH deficiency due to cranial irradiation

Medical and Pediatric Oncology

Volumn 34, Issue 1, 2000, Pages 14-19

  Adan, L ^a   Sainte Rose, C ^a   Souberbielle, J C ^a   Zucker, J M ^b   Kalifa, C ^c   Brauner, R ^a,d  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSTITUT CURIE   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d Institut Gustave Roussy ^*  (France)

Author keywords

Cranial irradiation; Cranial tumors; Growth hormone deficiency; Growth hormone treatment; Leukemia; Precocious puberty

Indexed keywords

GONADORELIN DERIVATIVE; GROWTH HORMONE DERIVATIVE;

ARTICLE; BODY HEIGHT; CATCH UP GROWTH; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; PRIORITY JOURNAL; RETINOBLASTOMA; SKULL IRRADIATION;

ADOLESCENT; ADULT; BODY HEIGHT; CHILD; CRANIAL IRRADIATION; FEMALE; GROWTH; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; MEDULLOBLASTOMA; PUBERTY; RETINOBLASTOMA; STATISTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033980378     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200001)34:1<14::AID-MPO3>3.0.CO;2-W     Document Type: Article

References (19)

1. Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res 1989;25:561-567.
2. Melin AE, Adan L, Leverger G, et al. Growth hormone secretion, puberty and adult height after cranial irradiation with 18 grays for leukemia. Eur J Pediatr 1998;157:703-707.
3. Adan L, Souberbielle JC, Blanche S, et al. Adult height after cranial irradiation with 24 Grays: factors and markers of height loss. Acta Pediatr 1996;85:1096-1101.
4. Sulmont V, Brauner R, Fontoura M, Rappaport R. Response to growth hormone treatment and final height after cranial or craniospinal irradiation. Acta Paediatr Scand 1990;79:542-49.
5. Brauner R, Rappaport R, Prevot C, et al. A prospective study of the development of growth hormone deficiency in children given cranial irradiation and its relation to statural growth. J Clin Endocrinol Metab 1989;68:346-351.
6. Brauner R, Adan L, Souberbielle JC, et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 1997;130:785-792.
7. Ogilvy-Stuart AL, Clayton PE, Shalet SM. Cranial irradiation and early puberty. J Clin Endocrinol Metab 1994;78:1282-1286.
8. Quigley C, Cowell C, Jimenez M, et al. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia. N Engl J Med 1989;321:143-151.
9. Shalet SM, Brennan BM, Reddingius RE. Growth hormone therapy and malignancy. Horm Res 1997;48 (suppl):29-32.
10. Adan L, Souberbielle JC, Zucker JM, et al. Adult height in 24 patients treated for growth hormone deficiency and early puberty. J Clin Endocrinol Metab 1997;82:229-233.
11. Sempé M, Pedron G, Roy-Pernot MP. Auxologie, méthode et séquences. Laboratoires Theraplix ed, Paris, 1979.
12. Tanner JM, Goldstein H, Whitehouse RH. Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child 1970;45:755-762.
13. nd ed. Stanford: Stanford Univ. Press; 1959.
14. Herber SM, Dunsmore IR, Milner RDG. Final stature in brain tumours other tban craniopharyngioma : effect of growth hormone. Hormone Res 1985;22:63-67.
15. Clayton PE, Shalet SM, Price DA. Growth response to growth hormone therapy following cranial irradiation. Eur J Pediatr 1988; 147:593-596.
16. Clayton PE, Shalet SM, Price DA. Growth response to growth hormone therapy following craniospinal irradiation. Eur J Pediatr 1988;147:597-601.
17. Ogilvy-Stuart AL, Shalet SM. Growth and puberty after growth hormone treatment after irradiation for brain tumours. Arch Dis Child 1995;73:141-146.
18. Pinto G, Adan L, Souberbielle JC, et al. Idiopathic growth hormone deficiency: presentation, diagnostic and treatment during childhood. Ann Endocr (Paris) 1999;60:224-231.
19. McGillivray MH, Baptista J, Johanson A. Outcome of a four-year randomized study of daily versus three times weekly somatropin treatment in prepubertal naive growth hormone-deficient children. J Clin Endocrinol Metab 1996;81:1806-1809.